Backbone 1H, 13C, and 15N resonance assignments for lysozyme from bacteriophage lambda. by Di Paolo, A, Duval, V, Matagne, A, Redfield, C

Backbone 1H, 13C, and 15N resonance assignments for lysozyme from bacteriophage lambda by Di Paolo, A, Duval, V, Matagne, A, Redfield, C

Biophysical approaches to protein folding and disease, a satellite meeting to the IUPAB-EBSA congress by Dalla Serra, M, Gilbert, R, Matagne, A, England, P

The dynamics of lysozyme from bacteriophage lambda in solution probed by NMR and MD simulations. by Smith, L, Bowen, A, Di Paolo, A, Matagne, A, Redfield, C

Rapid collapse into a molten globule is followed by simple two-state kinetics in the folding of lysozyme from bacteriophage λ. by Di Paolo, A, Balbeur, D, De Pauw, E, Redfield, C, Matagne, A

The origin of the alpha-domain intermediate in the folding of hen lysozyme. by Matagne, A, Chung, E, Ball, L, Radford, SE, Robinson, C, Dobson, C

Thermal unfolding of an intermediate is associated with non-Arrhenius kinetics in the folding of hen lysozyme. by Matagne, A, Jamin, M, Chung, E, Robinson, C, Radford, SE, Dobson, C

An NMR and MD study of complexes of bacteriophage lambda lysozyme with tetra- and hexa-n-acetylchitohexaose by Turupcu, A, Bowen, A, Di Paolo, A, Matagne, A, Oostenbrink, C, Redfield, C, Smith, L

The role of active site flexible loops in catalysis and of zinc in conformational stability of Bacillus cereus 569/H/9 β-lactamase. by Montagner, C, Nigen, M, Jacquin, O, Willet, N, Dumoulin, M, Karsisiotis, A, Roberts, G, Damblon, C, Redfield, C, Matagne, A

Reduced global cooperativity is a common feature underlying the amyloidogenicity of pathogenic lysozyme mutations. by Dumoulin, M, Canet, D, Last, A, Pardon, E, Archer, D, Muyldermans, S, Wyns, L, Matagne, A, Robinson, C, Redfield, C, Dobson, C

A nanobody binding to non-amyloidogenic regions of the protein human lysozyme enhances partial unfolding but inhibits amyloid fibril formation. by De Genst, E, Chan, P, Pardon, E, Hsu, S, Kumita, JR, Christodoulou, J, Menzer, L, Chirgadze, D, Robinson, C, Muyldermans, S, Matagne, A, Wyns, L, Dobson, C, Dumoulin, M

A camelid antibody fragment inhibits the formation of amyloid fibrils by human lysozyme. by Dumoulin, M, Last, A, Desmyter, A, Decanniere, K, Canet, D, Larsson, G, Spencer, A, Archer, D, Sasse, J, Muyldermans, S, Wyns, L, Redfield, C, Matagne, A, Robinson, C, Dobson, C

Engineering a camelid antibody fragment that binds to the active site of human lysozyme and inhibits its conversion into amyloid fibrils. by Chan, P, Pardon, E, Menzer, L, De Genst, E, Kumita, JR, Christodoulou, J, Saerens, D, Brans, A, Bouillenne, F, Archer, D, Robinson, C, Muyldermans, S, Matagne, A, Redfield, C, Wyns, L, Dobson, C, Dumoulin, M